Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Sofprint_Sopharma_EN_01.09.2025.pdfNotification from "Sofprint Group" AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 136 / 2025
Date of issue: 2025-09-03
Short name of the issuer
SOPHARMA AD
Subject
Notification from "Sofprint Group" AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma
Official market - legal basis
Art. 56. 1. 2 of Act on Public Offering
Unofficial market - legal basis
Contents of the report:
Notification from "Sofprint Group" AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma
Annexes
File Description
Sofprint_Sopharma_EN_01.09.2025.pdf
Sofprint_Sopharma_EN_01.09.2025.pdf		 Notification from "Sofprint Group" AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2025-09-03 Ognian Ivanov Donev Executive Director
20250903_151132_0565359466_Sofprint_Sopharma_EN_01.09.2025.pdf

Pobierz